Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Nucleai and Merck KGaA Darmstadt, Germany Launch Translational Medicine Collaboration Utilizing Nucleai’s AI-Powered Biomarker Platform
Saturday, June 26, 2021Nucleai a precision medicine company using AIpowered image analysis technology to support novel pathologybased biomarker development and Merck KGaA Darmstadt Germany a leading science and technology company announced that they have entered into a lon...
Eisai and Biogen Inc. Announce U.S. FDA Grants Breakthough Therapy Designation for Lecanemab (BAN2401), An Anti-amyloid Beta Protofibril Antibody for the Treatment of Alzheimer’s Disease
Thursday, June 24, 2021Eisai Co Ltd and Biogen Inc announced that the US Food and Drug Administration FDA has granted Breakthough Therapy designation for lecanemab BAN an investigational antiamyloid beta A protofibril antibody for the treatment of Alzheimers disease AD Bre...
Amgen Announces Approval Of Aimovig® (Erenumab) In Japan For The Suppression Of Onset Of Migraine Attacks In Adults
Thursday, June 24, 2021Amgen announced that the Japanese Ministry of Health Labour and Welfare has granted marketing approval for Aimovig erenumab for the suppression of onset of migraine attacks in adults Aimovig is the first and only approved treatment in Japan to block...
Eurofins Discovery and ImmunoPrecise Announce Collaboration to Expand their Antibody Discovery Platform
Wednesday, June 23, 2021IMMUNOPRECISE ANTIBODIES LTD the market leader in fullservice therapeutic discovery and development and Eurofins Discovery the leading provider of products and services to the drug discovery industry and a Eurofins Scientific ParisERF company announc...
Grace Science Receives U.S. FDA Orphan Drug Designation for GS-100, an AAV9 Gene Therapy for NGLY1 Deficiency
Wednesday, June 23, 2021Grace Science LLC announced today that the US Food and Drug Administration FDA has granted orphan drug designation to GS an investigational AAV gene replacement therapy for the treatment of NGLY deficiency The FDA grants orphan drug designation to in...
Arrowhead Pharmaceuticals and Horizon Therapeutics Announce Collaboration to Develop RNAi Therapeutic for Uncontrolled Gout
Tuesday, June 22, 2021Arrowhead Pharmaceuticals Inc and Horizon Therapeutics plc today announced a global collaboration and license agreement for AROXDH a previously undisclosed discoverystage investigational RNA interference RNAi therapeutic being developed by Arrowhead...
QIAGEN Launches Dedicated CRISPR Products for Rapid and Simplified Analysis of Gene-Editing Experiments
Tuesday, June 22, 2021QIAGEN announced the launch of QIAprepamp CRISPR Kit and CRISPR QPrimer Solutions that allow researchers to analyze edited genetic material with unparalleled speed and efficiency to determine how their interventions have changed the function of the D...
Bioheng Biotech received Orphan Drug Designation from the U.S. FDA for the treatment of T-ALL.
Monday, June 21, 2021Nanjing Bioheng Biotech Co Ltd Announced UCAR T cell therapy product targeting CD code CTD received Orphan Drug Designation ODD from the US Food and Drug Administration FDA for the treatment of Tcell acute lymphoblastic leukemia TALL CTD is the first...
Biotage Launches New Automated Platform for Plasmid DNA Purification
Monday, June 21, 2021Biotage is pleased to announce the launch of Biotage PhyPrep a new automated platform for plasmid DNA purification that releases laboratory staff from the tedium of repetitive manual labor and takes full advantage of the PhyTip columns dual flow chr...
CytRx Notes Orphazyme’s Regulatory Update from the FDA on Arimoclomol for Niemann-Pick Disease Type C
Saturday, June 19, 2021CytRx Corporation a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories today noted that Orphazyme AS announced it has received a Complete Response Letter CRL from the US...
